Tag: <span>cancer therapies</span>

Home / cancer therapies
Blocking sugar metabolism slows lung tumour growth
Post

Blocking sugar metabolism slows lung tumour growth

by Emily Packer, Ecole Polytechnique Federale de Lausanne Blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer, suggests a new study in mice and human cells published today in eLife. Cancer cells use a lot of sugar to fuel their rapid growth and spread. This has led scientists to...

Newly Synthesized Fungal Compound Can Switch on a Self-destruct Button for Cancer
Post

Newly Synthesized Fungal Compound Can Switch on a Self-destruct Button for Cancer

Leading organic chemists synthesize fungal molecule capable of reactivating the self-destruct gene in aggressive cancer cells. Cancers cells use a special technique to propagate; they delete their “programmed death” gene through mutation, “forget” to die when their lifetime is over and continue to grow instead. A research team from Tokyo University of Science has developed...

Brain study finds a molecular “off” switch for nicotine craving
Post

Brain study finds a molecular “off” switch for nicotine craving

Like any addiction, nicotine dependence warps the brain in elaborate ways—which is why treating it tends not to be as simple as mastering one’s willpower. Even after trying every technique in the toolbox—the support of friends, family, and a great therapist; nicotine patches; prescription drugs—many smokers will sooner or later experience a craving of overpowering...

Post

Novel compound shows promise for ANCA-associated vasculitis

Reviewed by Emily Henderson, B.Sc. ANCA-associated vasculitis (AAV) is a systemic disease involving the formation of special autoantibodies (so-called anti-neutrophil cytoplasmic antibodies/ANCA) and vascular inflammation. There are several diseases associated with involvement of the kidneys, lungs, upper respiratory tract, heart, skin and the nervous system; potentially life-threatening courses of disease are also possible. Immunosuppressive therapy...

Post

Growth factors and Parkinson’s disease — Where next?

Amsterdam, NL, June 4, 2020 – Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson’s disease (PD), but trials have been disappointing. A panel of prominent leaders in the field convened to discuss whether there is a future for this approach and what any...

Reusable Textiles to Repel Viruses
Post

Reusable Textiles to Repel Viruses

Prostate cancer therapies have shown significant advances during the past decade, with multiple new therapies being introduced for patients with advanced disease. Now, the early results of a clinical trial published in the New England Journal of Medicine (NEJM) reveals for the first time that therapies based on tumor genetics – specifically DNA repair defects...

Post

Reducing early brain inflammation could slow Alzheimer’s progression

CREDIT: GIORGIA MENEGONI, SAPIENZA, UNIVERSITY OF ROME Bethesda, MD – In a new animal study examining Alzheimer’s disease, researchers found that disease progression could be slowed by decreasing neuroinflammation in the brain before memory problems and cognitive impairment were apparent. The new findings point to the importance of developing therapies that target very early stages...

Post

‘Ancient’ cellular discovery key to new cancer therapies

Metabolic system may explain tumour growth in humans FLINDERS UNIVERSITY Australian researchers have uncovered a metabolic system which could lead to new strategies for therapeutic cancer treatment. A team at Flinders University led by Professor Janni Petersen and the St Vincent’s Institute of Medical Research have found a link between a metabolic system in a...